SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor ...

Shares of ANAB stock opened at $16.06 on Tuesday. The firm has a market cap of $488.71 million and a P/E ratio of -2.64. The firm’s 50 day moving average price is $17.05 and its 200-day moving ...

AnaptysBio (NASDAQ:ANAB – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Wedbush in a research note issued to investors on Monday,RTT News reports.

One stock that might be an intriguing choice for investors right now is AnaptysBio, Inc. ANAB. This is because this security in the Medical - Biomedical and Genetics space is seeing solid earnings ...

ANAB Scope Extension Blosters Firm’s Auditing and Verification CapabilitiesDES MOINES, Iowa, Feb. 04, 2025 (GLOBE NEWSWIRE) - ...

Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The company’s shares closed yesterday at $16.08.

EcoEngineers (Eco), a consulting, auditing, and advisory firm with an exclusive focus on the energy transition and decarbonization, today announced two new scope extensions granted by the American ...

The firm increased its portfolio allocation in ANAB by 55.02% over the last quarter. Frazier Life Sciences Management holds 2,209K shares representing 7.26% ownership of the company. In its prior ...

DES MOINES, Iowa — EcoEngineers (Eco), a consulting, auditing, and advisory firm with an exclusive focus on the energy transition and decarbonization, today announced two new scope extensions granted ...

The ANAB scope accreditations are a testament to ... transparent processes strengthens their credibility and advances the energy transition,” said Shashi Menon, CEO of EcoEngineers.